REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Agel Transfuzni Sluzba A.S. (Czech Republic)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Agel Transfuzni Sluzba A.S. Profile Updated: December 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Agel Transfuzni Sluzba A.S. is a company in Czech Republic, with a head office in Sumperk. The company operates in the Pharmaceutical and Medicine Manufacturing sector. It was established on March 05, 2003. 50 - 99 (2023) employees currently work for Agel Transfuzni Sluzba A.S.. In 2022, the company reported a net sales revenue increase of 9.97%. Its’ total assets recorded a growth of 32.15%. In 2022, Agel Transfuzni Sluzba A.S.’s net profit margin increased by 0.29%.

Headquarters
Nemocnicni 1788/53
Sumperk; Olomoucky; Postal Code: 78701

Contact Details: Purchase the Agel Transfuzni Sluzba A.S. report to view the information.

Website: http://www.transfuznisluzba.cz

Basic Information
Total Employees:
Purchase the Agel Transfuzni Sluzba A.S. report to view the information.
Outstanding Shares:
Purchase the Agel Transfuzni Sluzba A.S. report to view the information.
Registered Capital:
Purchase the Agel Transfuzni Sluzba A.S. report to view the information.
Incorporation Date:
March 05, 2003
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Purchase this report to view the information.
Vice Chairman of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Agel Transfuzni Sluzba A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
9.97%▲
Total operating revenue
6.57%▲
Operating profit (EBIT)
24.86%▲
EBITDA
21.73%▲
Net Profit (Loss) for the Period
19.28%▲
Total assets
32.15%▲
Total equity
15.89%▲
Operating Profit Margin (ROS)
0.61%▲
Net Profit Margin
0.29%▲
Return on Equity (ROE)
0.4%▲
Quick Ratio
0.1%▲
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo